Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering
- PMID: 23023101
- PMCID: PMC3508375
- DOI: 10.1097/QAI.0b013e31827303d5
Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering
Abstract
Background: Increases in multimorbidity and obesity have been noted in HIV-infected populations in the current treatment era. Patterns of multimorbid disease clustering and the impact of obesity on multimorbidity are understudied in this population.
Methods: We examined obesity and multimorbidity patterns among 1844 HIV-infected patients in the UAB 1917 Clinic. Exploratory factor analysis was used to identify the underlying factor structure responsible for clustering. Patterns among the resulting morbidity factors by body mass index (BMI) category were explored. Multivariable logistic regression models were fit to identify predictors of multimorbidity cluster patterns.
Results: The prevalence of multimorbidity was 65% (1205/1844). Prevalence increased with progressive BMI categories from underweight (64%) to obese (79%). Three multimorbidity clusters were identified: "metabolic," including hypertension, gout, diabetes mellitus, and chronic kidney disease (range, 0.41-0.84; P < 0.001); "Behavioral," including mood disorders, dyslipidemia, chronic obstructive pulmonary disease, chronic ulcer disease, osteoarthritis, obstructive sleep apnea, and cardiac disorders (range, 0.32-0.57; P < 0.001); "Substance Use," including alcohol abuse, substance abuse, tobacco abuse, and hepatitis C (range, 0.53-0.89; P < 0.001). Obesity was associated with increased odds of multimorbidity (obese vs. normal BMI category: OR = 1.52, 95% CI: 1.15 to 2.00).
Conclusions: Three patterns of disease clustering were identified. Obesity was associated with a higher likelihood of multimorbidity. The management of multimorbidity and obesity will need to be addressed in future clinical practice guidelines to enhance long-term outcomes of HIV-infected patients in the current treatment era.
References
-
- Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7:69–76. - PubMed
-
- Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated With Increased Multimorbidity Among Aging Injection Drug Users. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;53:1256–64. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AI027767/AI/NIAID NIH HHS/United States
- U2R TW006246/TW/FIC NIH HHS/United States
- 1K07AG31779/AG/NIA NIH HHS/United States
- R18-HS017786-02/HS/AHRQ HHS/United States
- 1R24 AI067039-1/AI/NIAID NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- 1R21HS019516-01/HS/AHRQ HHS/United States
- 5 T32 HS013852/HS/AHRQ HHS/United States
- R21 CA124336/CA/NCI NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R21 HS019516/HS/AHRQ HHS/United States
- P30-AI27767/AI/NIAID NIH HHS/United States
- R18 HS017786/HS/AHRQ HHS/United States
- T32 HS013852/HS/AHRQ HHS/United States
- R01 AG015062/AG/NIA NIH HHS/United States
- UB4HP19045/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Medical